Istituto Oncologico Veneto IRCCS clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.
- Minor: VIrtual Reality Induced Pain and anxiEty Relief in Outpatient UROlogical Procedures Primary and study completion dates pushed to Dec 31, 2026
- Minor: ScarABEO · Scarless Advanced Breast Extended Oncoplasty: The ScarABEO Study Primary completion pushed from Oct 1, 2026 to Dec 1, 2026
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-19 | NCT07948200 Urinary DNA Methylation Testing (Bladder EpiCheck®) and Its Peri-operative Kinetics for… | Not Yet Recruiting | |
| 2026-11-10 | NCT07927777 Relugolix in Patients With High-risk, Localized or Locally Advanced Prostate Cancer Who… | Phase 3 | Not Yet Recruiting |
| 2026-10-30 | NCT07906080 Study to Evaluate the Feasibility and Safety of Autologous Cytokine-Induced Killer Cells… | Phase 1 | Not Yet Recruiting |
Active trials by phase
| Phase 1 | 1 | |
| Phase 2 | 2 | |
| Phase 3 | 1 |
Not charted: 14 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 14
Breast Cancer (3) · Colorectal Cancer (3) · Bladder Cancer (2) · Prostate Cancer (2) · Sarcoma (2) · Acute Lymphoblastic Leukemia (ALL) (1) · Anxiety (1) · DLBCL (1) · Glioma (1) · Leukemia (1)
Get alerts when Istituto Oncologico Veneto IRCCS's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.